CD8A and cancer: The function of MDSCs in cancer is inhibiting T cell function, that exacerbate cancer [32], but MDSCs might alleviate ischemic injury by suppression of detrimental responses of γδ T cells, CD4+ T cells, and CD8+ T cells, which contribute to ischemic injury [33, 34].